AIDA 2000 Guidelines
- Conditions
- First Posted Date
- 2010-02-08
- Last Posted Date
- 2020-10-14
- Target Recruit Count
- 600
- Registration Number
- NCT01064570
- Locations
- 🇮🇹
A.O Umberto I, Roma, Italy
🇮🇹Unità Operativa Ematologia 1 - Università degli Studi di Bari, Bari, Italy
🇮🇹Div. di Ematologia IRCCS Policlinico S. Matteo, Pavia, Italy
Ph+/Bcr-Abl+ ALL Imatinib and Nilotinib Rotational Study
- Conditions
- First Posted Date
- 2009-12-03
- Last Posted Date
- 2022-10-12
- Target Recruit Count
- 40
- Registration Number
- NCT01025505
- Locations
- 🇮🇹
Osp. Reg. A. Di Summa, Brindisi, Italy
🇮🇹Clinica Ematologica - Università degli Studi, Genova, Italy
🇮🇹U.O. Ematologia, Azienda Ospedaliera Universitaria Senese, Siena, Italy
Mid-to Long-Term Outcomes in Chronic Myeloid Leukemia (CML) Patients With Complete Cytogenetic Response After Imatinib as First Line Therapy
- First Posted Date
- 2009-05-11
- Last Posted Date
- 2014-01-22
- Target Recruit Count
- 448
- Registration Number
- NCT00896129
- Locations
- 🇮🇹
Università di Pisa, Azienda Ospedaliera Pisana, Pisa, Italy
🇮🇹Policlinico G.B. Rossi, Verona, Italy
🇮🇹Azienda Ospedaliera Pugliese Ciaccio, Catanzaro, Italy
Quality of Life and Symptoms in Patients With Newly Diagnosed Myelodysplastic Syndromes
- Conditions
- First Posted Date
- 2008-12-17
- Last Posted Date
- 2020-12-22
- Target Recruit Count
- 927
- Registration Number
- NCT00809575
- Locations
- 🇺🇸
Memorial Sloan-Kettering Cancer Center (MSKCC), New York, New York, United States
🇺🇸The University of Texas, MD Anderson Cancer Center, Houston, Texas, United States
🇦🇹Innsbruck University Hospital, Innsbruck, Austria
Clofarabine and Temsirolimus in Treating Older Patients With Relapsed or Refractory Acute Myeloid Leukemia
- Conditions
- First Posted Date
- 2008-10-20
- Last Posted Date
- 2017-11-09
- Target Recruit Count
- 60
- Registration Number
- NCT00775593
- Locations
- 🇮🇹
Policlinico G. B. Rossi - Borgo Roma, Verona, Italy
🇮🇹Ospedale S. Eugenio, Roma, Italy
🇮🇹S.C. di Ematologia e Trapianti - I.F.O. Istituto Nazionale Tumori Regina Elena, Roma, Italy
Nilotinib and Imatinib Mesylate in Treating Patients With Early Chronic Phase Chronic Myelogenous Leukemia
- Conditions
- First Posted Date
- 2008-10-09
- Last Posted Date
- 2022-01-04
- Target Recruit Count
- 129
- Registration Number
- NCT00769327
- Locations
- 🇮🇹
Centro Oncologico Basilicata, Rionero in Vulture, Potenza, Italy
🇮🇹Unità di Oncoematologia Azienda Ospedaliera Garibaldi, Catania, Italy
🇮🇹Dip. di Scienze Cliniche e Biologiche - Ospedale S. Luigi Gonzaga, Orbassano, Italy
Lenalidomide, Fludarabine & Cyclophosphamide in Advanced Chronic Lymphocytic Leukemia Not Responding to Therapy
- Conditions
- First Posted Date
- 2008-08-04
- Last Posted Date
- 2019-01-22
- Target Recruit Count
- 42
- Registration Number
- NCT00727415
- Locations
- 🇮🇹
Istituto Scientifico Romagnoli per lo Studio e la Cura dei Tumori- IRST, Meldola, Italy
🇮🇹Unità Operativa Ematologia 1 - Università degli Studi di Bari, Bari, Italy
🇮🇹Istituto di Ematologia e Oncologia Medica "Lorenzo e A. Seragnoli" - Università degli Studi di Bologna - Policlinico S. Orsola - Malpighi, Bologna, Italy
Prednisone or Dexamethasone in Newly Diagnosed, Previously Untreated Primary Immune Thrombocytopenic Purpura
- Conditions
- Interventions
- First Posted Date
- 2008-04-14
- Last Posted Date
- 2017-02-20
- Target Recruit Count
- 150
- Registration Number
- NCT00657410
- Locations
- 🇮🇹
S.O.C. di Ematologia - Azienda Ospedaliera - SS. Antonio e Biagio e Cesare Arrigo, Alessandria, Italy
🇮🇹USL 8 - Ospedale S.Donato, Arezzo, Italy
🇮🇹UO Ematologia con trapianto- AOU Policlinico Consorziale di Bari, Bari, Italy
DaunoXome + Ara-C vs Daunorubicin + Ara-C in Elderly AML
Adult ALL Treatment at Diagnosis
- Conditions
- Locations
- 🇮🇹
Ist.Ematologia e Oncologia Medica L.e A. Seragnoli, Bologna, Italy
🇮🇹Ospedale Reg. A di Summa, Brindisi, Italy
🇮🇹Istituto di Ematologia- Ospedale San Carlo, Potenza, Italy